UK Markets closed
  • NIKKEI 225

    28,930.11
    -628.99 (-2.13%)
     
  • HANG SENG

    29,236.79
    -643.63 (-2.15%)
     
  • CRUDE OIL

    64.07
    +2.79 (+4.55%)
     
  • GOLD FUTURES

    1,694.40
    -21.40 (-1.25%)
     
  • DOW

    30,781.73
    -488.36 (-1.56%)
     
  • BTC-GBP

    34,475.48
    -2,213.72 (-6.03%)
     
  • CMC Crypto 200

    959.44
    -27.77 (-2.81%)
     
  • Nasdaq

    12,683.09
    -314.66 (-2.42%)
     
  • ^FTAS

    3,792.09
    -16.15 (-0.42%)
     

Vance Street Capital Appoints J. Mark King as Operating Partner

·2-min read

Vance Street Capital ("Vance Street"), a Los Angeles-based private equity firm, today announced the addition of J. Mark King as an Operating Partner, effective immediately. Mr. King will work closely with leadership teams of portfolio companies in the medical vertical to help set and achieve strategic objectives and budgetary goals. In addition, Mr. King will collaborate with the Vance Street investment team and support buy-side and sell-side processes for new medical device and components opportunities.

Prior to joining Vance Street, Mr. King held numerous executive leadership roles in the medical device market, both in branded product lines and in contract manufacturing. Most recently he served as President and Chief Executive Officer of Tegra Medical, a leading medical device contract manufacturer. Prior to Tegra, Mr. King was President and Chief Executive Officer of Clinical Innovations, a market leader in women’s health medical devices. In addition to Tegra Medical and Clinical Innovations, Mr. King has held senior positions at Baxter Healthcare, Cardinal Health and Johnson and Johnson.

"I’ve known the Vance Street team for many years and believe they are some of the best in the business when it comes to partnering with management teams to help them grow their organizations and transform unique solutions providers into larger strategic assets," said Mark King. "I’m excited to join the team and leverage my past industry and operating experience as we continue to build best-in-class organizations and support their continued development."

Mike Janish, Managing Partner at Vance Street, adds, "We could not be more excited to have Mark join our team given his longstanding track record of success across numerous businesses in the medtech space. Mark brings highly relevant industry and operating experience across a range of disciplines and markets that will greatly benefit our portfolio company management teams as well as aid in our evaluation of new investment opportunities."

"The addition of Mark further strengthens our commitment to partnering with founders and entrepreneurs through providing operational resources in a way that preserves each business’s culture while enhancing the engineered solutions they provide their customers," said Brian Martin, Managing Partner at Vance Street.

About Vance Street Capital LLC

Vance Street Capital is a middle-market private equity firm focused on investing in highly engineered solutions businesses across the medical, life science, industrial, aerospace and defense sectors. For over two decades, Vance Street’s partners have worked with management teams and family owners to accelerate revenue growth, improve operations and acquire strategic assets for the companies in their investment portfolio. For more information please visit: www.vancestreetcapital.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210119005319/en/

Contacts

Mickey Mandelbaum or Nick Rust
Prosek Partners
(646) 818-9252
mmandelbaum@prosek.com / nrust@prosek.com